FDAFDA · Food and drugs·Recall number D-1370-2020
Clozapine Tablets USP tablet, 100mg, 500-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-846-05
Published July 1, 2020 · Recall initiated: June 12, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CLOZAPINE
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- U.S.A. Nationwide
- UPC
- 0365862844019
- Lot
- Lot #: CZSC20003-A, Exp 1/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.